FIELD: new medical agent intended to normalize immune status of organism. SUBSTANCE: antiinflammatory and antimicrobial agent - chlobasol - is used in the capacity of immunomodulator, particularly for treatment of chronic bronchitis with derangements of immune status. Chlobasol is administered at the rate of one tablet (0.1 g) three times a day for 14 days. As compared with known immunomodulator (levamisol), chlobasol features not only immunocorrecting but also antiinflammatory and antimicrobial effect. As distinct from levamisol, it is not toxic. EFFECT: new antiinflammatory and antimicrobial agent - chlobasol - is used in a new function, as immunomodulator.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING DISTURBED IMMUNITY IN PATIENTS WITH CHRONIC BRONCHITIS | 1988 |
|
RU2050002C1 |
| BRONCHOLYTHIC AGENT | 1984 |
|
RU2024255C1 |
| METHOD FOR TREATING CHRONIC NONSPECIFIC PULMONARY DISEASES | 2000 |
|
RU2192907C2 |
| METHOD FOR EVALUATING INFECTION-DEPENDENT BRONCHIAL ASTHMA SEVERITY DEGREE | 2000 |
|
RU2182333C2 |
| METHOD FOR TREATMENT OF PATIENT WITH CHRONIC OBSTRUCTIVE LUNG DISEASE | 2005 |
|
RU2293556C2 |
| METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA | 2007 |
|
RU2348431C1 |
| METHOD FOR TREATING THE CASES OF BRONCHIAL ASTHMA | 2005 |
|
RU2288715C2 |
| METHOD OF DIAGNOSTICS OF PREASTHMA OF PATIENTS HAVING DUST OBSTRUCTIVE BRONCHITIS | 0 |
|
SU1169618A1 |
| METHOD FOR REMOVING IMMUNE DISTURBANCES IN CASES OF BRONCHIAL ASTHMA | 1996 |
|
RU2130307C1 |
| METHOD OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2008 |
|
RU2372948C1 |
